rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kristen M. Oelschlager

Chief Operating Officer

Company insider

Files Form 4 as: Chief Operating Officer, Castle Biosciences.

In numbers

Trades disclosed
116
Buys
0
Sells
18
Bought
$0
Sold
$7.3M
Companies
1
Companies where not an officer
0
First trade
27 Sep 2021
Last trade
1 Oct 2026
Last filed
5 Oct 2026

Companies traded

Where they are an officer
CSTL Castle BiosciencesOfficer · Diagnostics & Labs · last 1 Oct 20260 buys · 18 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
40Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
1 Oct 2026filed 5 Oct 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M$14K4,153 at $3.38filing
1 Oct 2026filed 5 Oct 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$100K2,807 at $35.75filing
1 Oct 2026filed 5 Oct 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$49K1,346 at $36.38filing
1 Oct 2026filed 5 Oct 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—4,153 at $0.00filing
1 Sep 2026filed 3 Sep 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M$14K4,152 at $3.38filing
1 Sep 2026filed 3 Sep 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$132K3,952 at $33.36filing
1 Sep 2026filed 3 Sep 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$6,804200 at $34.02filing
1 Sep 2026filed 3 Sep 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—4,152 at $0.00filing
1 Sep 2026filed 3 Sep 2026CSTL Castle Biosciencesoption or derivative · Diagnostics & LabsSEC FORM 4 Code M—4,152 at $0.00filing
1 Sep 2026filed 3 Sep 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Code M$14K4,152 at $3.38filing
1 Sep 2026filed 3 Sep 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$132K3,952 at $33.36filing
1 Sep 2026filed 3 Sep 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$6,804200 at $34.02filing
25 Aug 2026filed 26 Aug 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$245K7,161 at $34.26filing
25 Aug 2026filed 26 Aug 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$181K5,223 at $34.64filing
25 Aug 2026filed 26 Aug 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$245K7,161 at $34.26filing
25 Aug 2026filed 26 Aug 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$181K5,223 at $34.64filing
24 Aug 2026filed 26 Aug 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$412K12,218 at $33.69filing
24 Aug 2026filed 26 Aug 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$412K12,218 at $33.69filing
3 Aug 2026filed 5 Aug 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$87K3,000 at $29.12filing
3 Aug 2026filed 5 Aug 2026CSTL Castle BiosciencesDiagnostics & LabsSEC FORM 4 Sold$135K4,486 at $30.00filing

News

Sectors

Health Care18

Buys in green, sells in red, by the company’s sector.

Related people

Derek J. MaetzoldPres. & Chief Exec. Officer · Pres. & Chief Exec. Officer at Castle Biosciences, filing Form 4 there in the last year
Tobin W. JuvenalChief Commercial Officer · Chief Commercial Officer at Castle Biosciences, filing Form 4 there in the last year
Frank StokesChief Financial Officer · Chief Financial Officer at Castle Biosciences, filing Form 4 there in the last year
Miles HarrisonDirector · Director at Castle Biosciences, filing Form 4 there in the last year
Ellen GoldbergDirector · Director at Castle Biosciences, filing Form 4 there in the last year